Jim Simons's position in Aquestive Therapeutics is currently worth $5.72 Million. That's 0.01% of their equity portfolio (1213th largest holding). The investor owns 1.91% of the outstanding Aquestive Therapeutics stock. The first Aquestive Therapeutics trade was made in Q4 2019. Since then Jim Simons bought shares eight more times and sold shares on seven occasions. The stake costed the investor $2.26 Million, netting the investor a gain of 153% so far.